Table 4 Incidence, and hazard ratio of bipolar disorders between patients with hepatitis infection with and without treatment
From: Association of viral hepatitis and bipolar disorder: a nationwide population-based study
Variables | N | Event | PY | % | Crude HR (95% CI) | Adjusted HR†(95% CI) |
|---|---|---|---|---|---|---|
Hepatitis infection | ||||||
 Without treatment | 44,461 | 54 | 262,819 | 2.05 | 1.00 | 1.00 |
Only HBV treatment | ||||||
 Lamivudine, telbivudine, adefovir, tenofovir, and entecavir | 2151 | 2 | 11,820 | 1.69 | 0.82 (0.20, 3.36) | 0.85 (0.21, 3.53) |
Only HCV treatment | ||||||
 Ribavirin, interferon | 1081 | 2 | 6623 | 3.02 | 1.48 (0.36, 6.05) | 1.29 (0.31, 5.37) |
Both HBV&HCV treatment | 522 | 0 | 3634 | 0.00 | – | – |